Clinical Trial Update: ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial (ACCESS) comparing Eritoran tetrasodium to placebo in patients with severe sepsis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Eritoran tetrasodium (eritoran tetrasodium)

Snippet

Sponsor: Eisai Inc. | Conditions: Severe Sepsis | Phase 3 | Status: COMPLETED